Skip to main
ESPR
ESPR logo

Esperion Therapeutics (ESPR) Market Capitalization Overview

Market Cap: $231.90M as of Jun 13, 2025

$231.90M
Past Month+$77.86M (50.54%)
As of Jun 13, 2025, Esperion Therapeutics (ESPR) has a market capitalization of $231.90M. Over the past 30 days, its market cap has decreased by -6.62%, while in the last 12 months, it has decreased by -46.5%.

Market capitalization represents the total value of Esperion Therapeutics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Esperion Therapeutics (ESPR) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Esperion Therapeutics (ESPR) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Esperion Therapeutics (ESPR) Market Cap History

DateMarket CapChange
Jun 2, 2025$182.07M-6.62%
May 1, 2025$194.98M-30.11%
Apr 1, 2025$278.97M-10.39%
Mar 3, 2025$311.32M-12.71%
Feb 3, 2025$356.64M-17.73%
Jan 2, 2025$433.48M-29.03%

Esperion Therapeutics (ESPR) End of Year Market Cap History

DateMarket CapChange
2025$231.90M-46.50%
2024$433.48M+27.49%
2023$340.02M-25.93%
2022$459.05M+215.74%
2021$145.39M-79.94%
2020$724.80M

FAQs About Esperion Therapeutics (ESPR) Market Cap

As of Jun 13, 2025, the market capitalization of Esperion Therapeutics (ESPR) is $231.90M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Esperion Therapeutics’s market capitalization has increased by 50.54%, changing from $154.05M to $231.90M as of Jun 13, 2025.

In the last 3 months, Esperion Therapeutics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Esperion Therapeutics’s market capitalization increased from $340.02M in January to $433.48M in December, reflecting a 27.49% change.

In the past five years, Esperion Therapeutics (ESPR) has had a compound annual growth rate (CAGR) of -9.77% in market capitalization. This means its market cap has shrunk at an average rate of -9.77% per year.

Esperion Therapeutics (ESPR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.